HS6ST2 Kit ELISA

N° du produit ABIN2043629

Détail du produit HS6ST2 Kit ELISA

Antigène: HS6ST2 (Heparan Sulfate 6-O-Sulfotransferase 2 (HS6ST2))

Reactivité: Humain

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Gamme de detection: 0.15-10 ng/mL

Seuil minimal de détection: 0.15 ng/mL

Application: ELISA

Marque: BioAssay™

Sensibilité: < 0.053 ng/mL

Information d'application

Plaque: Pre-coated

Protocole: Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2) BioAssay-ELISA Kit (Human) is a Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm±10nm. The concentration of Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Restrictions: For Research Use only

Stockage

Stock: 4 °C/-20 °C

Détail du antigène

Antigène: HS6ST2 (Heparan Sulfate 6-O-Sulfotransferase 2 (HS6ST2))

Autre désignation: Heparan Sulfate-6-O-Sulfotransferase 2 (HS6ST2) (HS6ST2 Produits)

Synonymes: 6OST2 Kit ELISA, RGD1563872 Kit ELISA, RGD1564397 Kit ELISA, HS6ST-2 Kit ELISA, fb80f12 Kit ELISA, hs6st Kit ELISA, wu:fb80f12 Kit ELISA, heparan sulfate 6-O-sulfotransferase 2 Kit ELISA, HS6ST2 Kit ELISA, Hs6st2 Kit ELISA, hs6st2 Kit ELISA

Pathways: Glycosaminoglycan Metabolic Process, SARS-CoV-2 Protein Interactome